Cargando…

Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock

Motility is a commonly used in vitro phenotype for assessing anthelmintic activity of candidate compounds, and for detecting anthelmintic resistance in nematodes. Third-stage larvae (L3) of parasitic nematodes are commonly used in motility-based assays because L3 are simple to obtain and can remain...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Melissa M., Lopez-Soberal, Lorraine, Storey, Bob E., Howell, Sue B., Kaplan, Ray M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114081/
https://www.ncbi.nlm.nih.gov/pubmed/29274827
http://dx.doi.org/10.1016/j.ijpddr.2017.12.002
_version_ 1783351132268003328
author George, Melissa M.
Lopez-Soberal, Lorraine
Storey, Bob E.
Howell, Sue B.
Kaplan, Ray M.
author_facet George, Melissa M.
Lopez-Soberal, Lorraine
Storey, Bob E.
Howell, Sue B.
Kaplan, Ray M.
author_sort George, Melissa M.
collection PubMed
description Motility is a commonly used in vitro phenotype for assessing anthelmintic activity of candidate compounds, and for detecting anthelmintic resistance in nematodes. Third-stage larvae (L3) of parasitic nematodes are commonly used in motility-based assays because L3 are simple to obtain and can remain viable in storage for extended periods. To improve the measurement of motility of microscopic stages of nematodes, our laboratory developed the Worminator, which quantitatively measures motility of parasites. Using the Worminator, we compared the dose-response characteristics of several avermectin/milbemycin (AM) compounds using L3 from both AM-susceptible and AM-resistant Cooperia spp. (abamectin, doramectin, eprinomectin, ivermectin, moxidectin) and Haemonchus contortus (eprinomectin, ivermectin, moxidectin). Concentrations tested with the Worminator ranged from 0.156 to 40 μM. Differences in EC(50) between AM-susceptible and AM-resistant isolates of Cooperia spp. and Haemonchus contortus were small, with resistance ratios ranging from 1.00 to 1.34 for Cooperia spp., 0.99 to 1.65 for Haemonchus contortus. Larval migration inhibition assays were conducted using the same isolates and were equally ineffective for detection of resistance with resistance ratios less than 2.0. These results contrast with those of the Larval Development Assay where we obtained a resistance ratio of 16.48 using the same isolates of Haemonchus contortus. Moreover, even at the highest concentration tested (40 μM), 100% inhibition of motility was never achieved and EC(50) for Worminator assays were more than 100× higher than peak plasma levels achieved in vivo following treatment. These data demonstrate that dose-response characteristics for inhibition of motility in L3 of gastrointestinal nematodes of livestock do not significantly differ for AM-susceptible and AM-resistant isolates. These data challenge the suitability of motility as a phenotype for detecting and measuring resistance to AM drugs in gastrointestinal nematodes of livestock.
format Online
Article
Text
id pubmed-6114081
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61140812018-08-31 Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock George, Melissa M. Lopez-Soberal, Lorraine Storey, Bob E. Howell, Sue B. Kaplan, Ray M. Int J Parasitol Drugs Drug Resist Article Motility is a commonly used in vitro phenotype for assessing anthelmintic activity of candidate compounds, and for detecting anthelmintic resistance in nematodes. Third-stage larvae (L3) of parasitic nematodes are commonly used in motility-based assays because L3 are simple to obtain and can remain viable in storage for extended periods. To improve the measurement of motility of microscopic stages of nematodes, our laboratory developed the Worminator, which quantitatively measures motility of parasites. Using the Worminator, we compared the dose-response characteristics of several avermectin/milbemycin (AM) compounds using L3 from both AM-susceptible and AM-resistant Cooperia spp. (abamectin, doramectin, eprinomectin, ivermectin, moxidectin) and Haemonchus contortus (eprinomectin, ivermectin, moxidectin). Concentrations tested with the Worminator ranged from 0.156 to 40 μM. Differences in EC(50) between AM-susceptible and AM-resistant isolates of Cooperia spp. and Haemonchus contortus were small, with resistance ratios ranging from 1.00 to 1.34 for Cooperia spp., 0.99 to 1.65 for Haemonchus contortus. Larval migration inhibition assays were conducted using the same isolates and were equally ineffective for detection of resistance with resistance ratios less than 2.0. These results contrast with those of the Larval Development Assay where we obtained a resistance ratio of 16.48 using the same isolates of Haemonchus contortus. Moreover, even at the highest concentration tested (40 μM), 100% inhibition of motility was never achieved and EC(50) for Worminator assays were more than 100× higher than peak plasma levels achieved in vivo following treatment. These data demonstrate that dose-response characteristics for inhibition of motility in L3 of gastrointestinal nematodes of livestock do not significantly differ for AM-susceptible and AM-resistant isolates. These data challenge the suitability of motility as a phenotype for detecting and measuring resistance to AM drugs in gastrointestinal nematodes of livestock. Elsevier 2017-12-18 /pmc/articles/PMC6114081/ /pubmed/29274827 http://dx.doi.org/10.1016/j.ijpddr.2017.12.002 Text en © 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
George, Melissa M.
Lopez-Soberal, Lorraine
Storey, Bob E.
Howell, Sue B.
Kaplan, Ray M.
Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title_full Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title_fullStr Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title_full_unstemmed Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title_short Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
title_sort motility in the l3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114081/
https://www.ncbi.nlm.nih.gov/pubmed/29274827
http://dx.doi.org/10.1016/j.ijpddr.2017.12.002
work_keys_str_mv AT georgemelissam motilityinthel3stageisapoorphenotypefordetectingandmeasuringresistancetoavermectinmilbemycindrugsingastrointestinalnematodesoflivestock
AT lopezsoberallorraine motilityinthel3stageisapoorphenotypefordetectingandmeasuringresistancetoavermectinmilbemycindrugsingastrointestinalnematodesoflivestock
AT storeybobe motilityinthel3stageisapoorphenotypefordetectingandmeasuringresistancetoavermectinmilbemycindrugsingastrointestinalnematodesoflivestock
AT howellsueb motilityinthel3stageisapoorphenotypefordetectingandmeasuringresistancetoavermectinmilbemycindrugsingastrointestinalnematodesoflivestock
AT kaplanraym motilityinthel3stageisapoorphenotypefordetectingandmeasuringresistancetoavermectinmilbemycindrugsingastrointestinalnematodesoflivestock